Real-World Evidence: Pediatric Neurodevelopment & Behavioral Dysregulation in Physician-Co-Managed Cohorts
Real-World Evidence: Pediatric Neurodevelopment & Behavioral Dysregulation in Physician-Co-Managed Cohorts
Observational outcomes from physician-supervised pediatric cohorts assessing behavioral stabilization, expressive communication emergence, and family quality-of-life. Derived from longitudinal physician evaluations across 81,008 unique clinical cohorts and 130,447 structured follow-up encounters at CED Clinic, informed by Dr. Benjamin Caplan’s career oversight of 350,000+ patient evaluations.
Methodology & Observational Grounding
Unlike traditional pharmaceutical clinical trials that restrict inclusion criteria to single-diagnosis participants devoid of concurrent medications, the CED Clinic Real-World Evidence Registry captures the complex clinical reality of outpatient cannabinoid medicine. Patients in this cohort were systematically evaluated under board-certified physician supervision, with structured longitudinal tracking of symptom burden, medication de-escalation, adverse event incidence, and chemovar responsiveness.
What does real-world evidence show regarding cannabinoids for Pediatric Neurodevelopment & Autism?
Pediatric cannabinoid therapy succeeds only within a collaborative co-management framework. Real-world observation highlights that precision, weight-based titration of non-intoxicating acidic and neutral cannabinoids substantially reduces sensory crisis frequency while maintaining rigorous hepatic safety.
What is the clinical scale and data provenance of this Pediatric Neurodevelopment & Autism analysis?
This analysis synthesizes real-world clinical observations from Dr. Benjamin Caplan, MD, who has overseen more than 350,000 patient evaluations across his career (including supervising 250,000+ patients as former Chief Medical Officer of Canna Care Docs). The specific dataset reflects 81,008 outpatient cohorts and 130,447 structured clinical visits tracked in the CED Clinic Clinical Registry.
Get the next evidence review in your inbox
Plain-language summaries of the newest cannabis research, written by a physician. Free to read, and you can unsubscribe at any time.
Join the growing cannabis community. Free. One-click subscribe. Delivered by Substack.
“Pediatric cannabinoid therapy succeeds only within a collaborative co-management framework. Real-world observation highlights that precision, weight-based titration of non-intoxicating acidic and neutral cannabinoids substantially reduces sensory crisis frequency while maintaining rigorous hepatic safety.”